428 related articles for article (PubMed ID: 25970001)
21. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3.
Paulson ML; Freeman AF; Holland SM
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):527-33. PubMed ID: 18978467
[TBL] [Abstract][Full Text] [Related]
22. Hyperimmunoglobulin E syndromes in pediatrics.
Zhang Q; Su HC
Curr Opin Pediatr; 2011 Dec; 23(6):653-8. PubMed ID: 21970826
[TBL] [Abstract][Full Text] [Related]
23. [Severe atopy and allergy--rare hyper-IgE syndrome caused by the DOCK8 mutation as underlying condition].
Koskenvuo M; Kainulainen L; Vanto T; Lukkarinen H; Lähteenmäki P; Ruuskanen O
Duodecim; 2015; 131(6):541-4. PubMed ID: 26237897
[TBL] [Abstract][Full Text] [Related]
24. Th17 cells, Job's syndrome and HIV: opportunities for bacterial and fungal infections.
Milner JD; Sandler NG; Douek DC
Curr Opin HIV AIDS; 2010 Mar; 5(2):179-83. PubMed ID: 20543597
[TBL] [Abstract][Full Text] [Related]
25. A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis.
Kasap N; Celik V; Isik S; Cennetoglu P; Kiykim A; Eltan SB; Nain E; Ogulur I; Baser D; Akkelle E; Celiksoy MH; Kocamis B; Cipe FE; Yucelten AD; Karakoc-Aydiner E; Ozen A; Baris S
Clin Immunol; 2021 Feb; 223():108645. PubMed ID: 33301882
[TBL] [Abstract][Full Text] [Related]
26. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
[TBL] [Abstract][Full Text] [Related]
27. Expansion of CCR4+ activated T cells is associated with memory B cell reduction in DOCK8-deficient patients.
Caracciolo S; Moratto D; Giacomelli M; Negri S; Lougaris V; Porta F; Pajno G; Salpietro A; Montin D; Dinwiddie DL; Kingsmore SF; Plebani A; Badolato R
Clin Immunol; 2014; 152(1-2):164-70. PubMed ID: 24674883
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis of hyper IgE syndrome.
Heimall J; Freeman A; Holland SM
Clin Rev Allergy Immunol; 2010 Feb; 38(1):32-8. PubMed ID: 19452285
[TBL] [Abstract][Full Text] [Related]
29. Hyper-IgE syndromes: reviewing PGM3 deficiency.
Yang L; Fliegauf M; Grimbacher B
Curr Opin Pediatr; 2014 Dec; 26(6):697-703. PubMed ID: 25365149
[TBL] [Abstract][Full Text] [Related]
30. An update on the hyper-IgE syndromes.
Yong PF; Freeman AF; Engelhardt KR; Holland S; Puck JM; Grimbacher B
Arthritis Res Ther; 2012 Nov; 14(6):228. PubMed ID: 23210525
[TBL] [Abstract][Full Text] [Related]
31. An Update on Syndromes with a Hyper-IgE Phenotype.
Bergerson JRE; Freeman AF
Immunol Allergy Clin North Am; 2019 Feb; 39(1):49-61. PubMed ID: 30466772
[TBL] [Abstract][Full Text] [Related]
32. Hyper IgE syndromes: A clinical approach.
Gharehzadehshirazi A; Amini A; Rezaei N
Clin Immunol; 2022 Apr; 237():108988. PubMed ID: 35351598
[TBL] [Abstract][Full Text] [Related]
33. DOCK8 deficiency.
Su HC; Jing H; Zhang Q
Ann N Y Acad Sci; 2011 Dec; 1246():26-33. PubMed ID: 22236427
[TBL] [Abstract][Full Text] [Related]
34. Multi-Omics Profiling in PGM3 and STAT3 Deficiencies: A Tale of Two Patients.
Jacob M; Masood A; Abdel Rahman AM
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768728
[TBL] [Abstract][Full Text] [Related]
35. Hyper-IgE syndrome.
Minegishi Y
Curr Opin Immunol; 2009 Oct; 21(5):487-92. PubMed ID: 19717292
[TBL] [Abstract][Full Text] [Related]
36. [Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review].
Heropolitańska-Pliszka E; Pietrucha B; Mikołuć B; Bernatowska E
Med Wieku Rozwoj; 2009; 13(1):19-25. PubMed ID: 19648655
[TBL] [Abstract][Full Text] [Related]
37. Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes T
Keles S; Charbonnier LM; Kabaleeswaran V; Reisli I; Genel F; Gulez N; Al-Herz W; Ramesh N; Perez-Atayde A; Karaca NE; Kutukculer N; Wu H; Geha RS; Chatila TA
J Allergy Clin Immunol; 2016 Nov; 138(5):1384-1394.e2. PubMed ID: 27350570
[TBL] [Abstract][Full Text] [Related]
38. Hyper IgE Syndromes.
Gracci S; Novelli T; D'Elios S; Bernardini R; Peroni D
Curr Pediatr Rev; 2024; 20(3):253-264. PubMed ID: 37702167
[TBL] [Abstract][Full Text] [Related]
39. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients.
Alsum Z; Hawwari A; Alsmadi O; Al-Hissi S; Borrero E; Abu-Staiteh A; Khalak HG; Wakil S; Eldali AM; Arnaout R; Al-Ghonaium A; Al-Muhsen S; Al-Dhekri H; Al-Saud B; Al-Mousa H
J Clin Immunol; 2013 Jan; 33(1):55-67. PubMed ID: 22968740
[TBL] [Abstract][Full Text] [Related]
40. Novel mutation in DOCK8-HIES with severe phenotype and successful transplantation.
Al Shekaili L; Sheikh F; Al Gazlan S; Al Dhekri H; Al Mousa H; Al Ghonaium A; Al Saud B; Al Mohsen S; Rehan Khaliq AM; Al Sumayli S; Al Zahrani M; Dababo A; AlKawi A; Hawwari A; Arnaout R
Clin Immunol; 2017 May; 178():39-44. PubMed ID: 27890707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
